Current Affairs News

First Danish Medical Cannabis Cultivation and Manufacturing License Awarded

medical cannabis
Written by Cara Wietstock

Cantiva ApS along with 3C Consulting, LLC are embarking to cultivate, manufacture, and distribute medical cannabis in Denmark.

Come January, Danes have more to celebrate than just ringing in the New Year. The Danish Parliament officially decided in 2016 to go online January 2018 with a four-year provisional medical cannabis program. In that time many companies applied for the 11 national cannabis cultivation and extraction/manufacturing licenses. The license application process was described as ‘rigorous’, and 3C Consulting, LLC together with Cantiva ApS were awarded the first of the eleven.

Aside from providing medical cannabis for Danish citizens, the program is being built to eventually become a valuable export for the country. The hopes are that a prosperous legal medical cannabis export industry could lead to lower prices for domestic patients. Throughout the trial program licensed Danish companies will be establishing new standards for pharmaceutical medical cannabis. All of these programs are aimed at furthering research, medical education, and patient care.

“These cultivation and extraction license wins establish a beachhead for 3C to expand further into Europe while bolstering our overall global expansion. This pivotal moment marks a new opportunity to do right by patients and we resolve to help set a new standard for the cannabis industry by leveraging what we have learned operating in 22 states and seven countries,” said Nic Easley, CEO of 3C.

Of the 5.7 million citizens in Denmark, 1,141,450 suffer from chronic pain, 300,000 are diagnosed with various types of cancer, and 12,800 have been diagnosed with Multiple Sclerosis (MS). All three of these conditions and spinal injuries will be qualifying conditions under the new Danish medical cannabis laws. The program will allow for treatment using capsules, pills, transdermal patches, topicals, and suppositories.

Cannabis is currently decriminalized in more than 10 European countries and legal in some form in less than five. Cantiva ApS won the first license with help from 3C Consulting, a company that is continuing their focus on expanding into the European market. The Danish regulators should issue the remaining licenses before the end of the year.

About the author

Cara Wietstock

Cara began working in the retail cannabis industry of San Francisco, CA in 2011 and continued in that sector for years. In 2015 she dedicated herself to writing full-time. Her passion for the written word and deep respect for the healing properties of the plant have brought her to Terpenes and Testing magazine. She now helps keep us on the cutting edge of scientific cannabis discovery as the Editor-in-Chief of the print publication.

Leave a Comment